Crucell has announced that it intends to move Dukoral and rCTB bulk production, formulation and fill or finish activities from Sweden to other sites within the Crucell organization, resulting in additional cost savings beyond 2011.
Subscribe to our email newsletter
As part of the Healthy Ambition program, Crucell’s operational excellence program, the formulation, filling and packaging of Dukoral in Sweden will stop during 2011 and will move to Spain. The bulk production of Dukoral and rCTB will stop in 2012 and will move to Switzerland.
The Nordic sales and customer Service and distribution activities will continue to operate from Solna in Sweden and research activities will be closed and concentrated in Leiden before year-end 2008.
Other important elements of the program are: product portfolio optimization, process and infrastructure optimization, network rationalization and further integration and streamlining of various functions.
Target savings of E30 million had already been identified and are expected to be achieved by the end of 2009.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.